Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance–related polycystic ovary syndrome
- 1 February 1999
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 71 (2) , 323-327
- https://doi.org/10.1016/s0015-0282(98)00454-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Dyslipidaemia in poly cystic ovarian syndrome: different groups, different aetiologies?Human Reproduction, 1996
- Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary SyndromeNew England Journal of Medicine, 1996
- Dyslipidaemia is associated with insulin resistance in women with polycystic ovariesClinical Endocrinology, 1996
- Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitusThe American Journal of Medicine, 1995
- Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with TroglitazoneNew England Journal of Medicine, 1994
- Troglitazone Prevents Glucose-Induced Insulin Resistance of Insulin Receptor in Rat-1 FibroblastsDiabetes, 1994
- Effect of New Oral Antidiabetic Agent CS-045 on Glucose Tolerance and Insulin Secretion in Patients with NIDDMDiabetes Care, 1991
- Insulin receptors in the central nervous system: Localization, signalling mechanisms and functional aspectsProgress in Neurobiology, 1991
- Insulin-Like Growth Factor I and Insulin Potentiate Luteinizing Hormone-Induced Androgen Synthesis by Rat Ovarian Thecal-Interstitial Cells*Endocrinology, 1988
- Insulin Enhancement of Luteinizing Hormone and Follicle-Stimulating Hormone Release by Cultured Pituitary Cells*Endocrinology, 1981